Genmab — Juli 2020

[Plimsoller]

Gor morgen

[Plimsoller]

*God

[E_L]

small new trial in China - Daratumumab Combined With Bortezomib and Dexamethasone in Mayo 04 Stage III Light Chain Amyloidosis https://clinicaltrials.gov/ct2/show/NCT04474938?term=genmab+OR+daratumumab+OR+darzalex+OR+ofatumumab+OR+Teprotumumab+OR+Tisotumab+OR+camidanlumab+OR+Enapotamab+OR+ADCT-301+OR+duobody&lupd_s=07%2F17%2F2020&draw=2&rank=3

[Helge_LarsenPI-redaktør]

God morgen.

[Plimsoller]

God morgen

[Stroka]

God morgen.

[Stroka]

Spændende at se om kursen holder sig oppe efter den stejle opkørsel fredag.

[E_L]

https://www.reuters.com/article/us-gsk-curevac-stake/gsk-to-take-10-stake-in-germanys-curevac-for-163-million-idUSKCN24L0JR GSK to take 10% stake in Germany's CureVac for $163 million

[nohope]

I don´t quite get it, they don´t get part of the existing vax against Covid and rabies, why do they call it taking a stake in Curevac then ? Is it some kind of cooperation for new vax instead ?

[Sukkeralf]

They buy 10% of the Company and get access to up to 5 new vaccine programs

[E_L]

and what they try to say in the article is that that the Covid program is NOT one of those 5

[E_L]

i think it is at a similar valuation to the German government. We still don't know the % stake Genmab holds, do we?

[BioShare]

@EL - it was just announced as an equity investment of 20 million euro. And we probably don't know the valuation of Curevac...

[nohope]

Ok, thanks.

[BioShare]

Think its approx 1,42% then...but difficult to have the exact valuation (CureVac was
around EUR1,4 billion in 2017).

[E_L]

Immunomodulatory and clinical effects of daratumumab in T‐cell acute lymphoblastic leukaemia https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.16960

[Helge_LarsenPI-redaktør]

Thanks E L. Prematurt - but it looks exciting.

[E_L]

yes, hopefully we'll get some real data from the PhII Delphinus ALL trial before the end of the year

[Stroka]

Sikken en klods i 2330-2331.

[Stroka]

Vupti..Den blev spist.